glp 1 meds canada Safety risks in the GLP-1 market: an update on weight loss medication, May 2026 – Partnership for Safe Medicines Canada Approves First Generic Semaglutide

This study highlights the need for further research of GLP-1RA in treating alcohol use disorder and substance use disorder [52]

Your clinician may weigh route and timing based on where your symptoms live

Billings noted that basal insulin and GLP-1 combinations led to low rates of these side effects throughout clinical trials

Anti-tuberculosis drug toxicity: An analysis of 1,198 patients across 5 studies found that silymarin, used at 140 mg to 420 mg daily, reduced the rate of drug-induced liver injury (measured by liver enzymes) associated with anti-tuberculosis drugs after 4 weeks of treatment (Tao, Can J Gastroenterol Hepatol, 2019) [36]